Page last updated: 2024-08-23

amikacin and chir 090

amikacin has been researched along with chir 090 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abramite, JA; Arcari, JT; Barham, RA; Brown, MF; Che, Y; Chen, JM; Chung, SW; Collantes, EM; Desbonnet, C; Doroski, M; Doty, J; Engtrakul, JJ; Harris, TM; Huband, M; Knafels, JD; Leach, KL; Liu, S; Marfat, A; Marra, A; McElroy, E; Melnick, M; Menard, CA; Montgomery, JI; Mullins, L; Noe, MC; O'Donnell, J; Oliver, R; Penzien, J; Plummer, MS; Price, LM; Reilly, U; Shanmugasundaram, V; Thoma, C; Uccello, DP; Warmus, JS; Wishka, DG1

Other Studies

1 other study(ies) available for amikacin and chir 090

ArticleYear
Potent inhibitors of LpxC for the treatment of Gram-negative infections.
    Journal of medicinal chemistry, 2012, Jan-26, Volume: 55, Issue:2

    Topics: Amidohydrolases; Animals; Anti-Bacterial Agents; Biphenyl Compounds; Catalytic Domain; Crystallography, X-Ray; Drug Resistance, Bacterial; Hydrogen Bonding; Hydroxamic Acids; Mice; Models, Molecular; Molecular Conformation; Phenyl Ethers; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Stereoisomerism; Structure-Activity Relationship; Sulfides; Sulfones

2012